ABRYSVO™: Pfizer’s Canada’s Newly Publicly Funded Vaccine a Step Towards National RSV Prevention in Older Adults
KIRKLAND, QC – Pfizer Canada ULC announced that ABRYSVO™ has been selected as the publicly-funded vaccine for the prevention of Respiratory Syncytial Virus (RSV) in older adults in Canada for… Read More




